This afternoon we watched CVS Health drop -1.1% to a price of $66.34 per share. The large-cap Pharmaceutical Retail company is now trading -27.54% below its average target price of $91.56. Analysts have set target prices ranging from $76.0 to $110.0 per share for CVS Health, and have given the stock an average rating of buy.
The stock has a very low short interest at 1.5%, and a short ratio of 2.13. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 79.9% of CVS Health's shares being owned by this investor type.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Vanguard Group Inc | 9% | 116,676,882 | $7,740,927,878 |
| 2023-06-30 | Blackrock Inc. | 7% | 93,734,850 | $6,218,838,737 |
| 2023-06-30 | State Street Corporation | 4% | 55,877,387 | $3,707,185,308 |
| 2023-06-30 | Morgan Stanley | 3% | 33,253,424 | $2,206,198,455 |
| 2023-06-30 | Capital World Investors | 2% | 30,490,802 | $2,022,912,295 |
| 2023-06-30 | Geode Capital Management, LLC | 2% | 23,325,287 | $1,547,516,194 |
| 2023-06-30 | FMR, LLC | 2% | 21,292,797 | $1,412,670,642 |
| 2023-06-30 | Invesco Ltd. | 1% | 17,002,487 | $1,128,030,020 |
| 2023-06-30 | Bank of America Corporation | 1% | 16,551,119 | $1,098,084,010 |
| 2023-06-30 | Dodge & Cox Inc | 1% | 16,024,422 | $1,063,140,297 |
Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on CVS Health.
